Vaxart, Inc. (OTCQX: VXRT) released topline 12-month safety data from the 400-participant sentinel safety cohort of its Phase 2b clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE